Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00582868 · ClinicalTrials.gov registry record
Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH
A clinical trial, sponsored by University of Wisconsin, Madison.
- Terminated
- Registry status
- 10
- Enrollment target
NCT00582868 is a clinical trial that was terminated before completion, run by University of Wisconsin, Madison. The registered enrollment target is 10 participants.
The verdict
NCT00582868 was terminated before completion, sponsored by University of Wisconsin, Madison.
- TERMINATED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to investigate if brain oxygen levels, levels of a specific protein in the cerebrospinal fluid and blood (Cleaved-tau protein), and brain blood flow can predict spasm of brain blood vessels after bleeding in the brain from a ruptured aneurysm.
Interventions
- DEVICE Licox Brain Oxygen Monitor
- OTHER CSF
- OTHER Whole blood
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2007-05 |
| Est. Completion | 2009-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00582868
The ClinicalTrials.gov registry entry for NCT00582868 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Wisconsin, Madison, which has 1,039 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Licox Brain Oxygen Monitor is the first listed.
NCT00582868 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00582868 about?
NCT00582868 is a clinical study titled "Use of Brain Oxygen Tension Level and Cleaved-tau Protein to Detect Vasospasm After SAH". The purpose of this study is to investigate if brain oxygen levels, levels of a specific protein in the cerebrospinal fluid and blood (Cleaved-tau protein), and brain blood flow can predict spasm of brain blood vessels after bleeding in the brain from a ruptured aneurysm.
What is the current status of trial NCT00582868?
This trial is currently terminated. The enrollment target is 10 participants. The study started on 2007-05. Estimated completion is 2009-05.
What interventions are being tested in trial NCT00582868?
The interventions under investigation include: Licox Brain Oxygen Monitor (DEVICE), CSF (OTHER), Whole blood (OTHER).
Who is sponsoring clinical trial NCT00582868?
This trial is sponsored by University of Wisconsin, Madison, which has 1,039 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.